Howard A. Liebman - Publications, H-index & Citations

Howard A. Liebman

university of southern california

57H指数

226论文数

1.6W被引数

收录论文 57

发表时间

Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial 利扎布鲁替尼在既往治疗过的免疫性血小板减少症患者中的临床活性和安全性（LUNA3）：一项III期试验开放标签期的结果

Lancet Haematology

IF17.7

2026-09-17

PREAI

David J Kuter; Waleed Ghanima; Nichola Cooper; Howard A Liebman; Lei Zhang; Yu Hu; Yoshitaka Miyakawa; Marie Luise Hütter-Krönke; Cristina Pascual-Izquierdo; Elisa Lucchini; Sylvain Audia; Matias Cordoba; Heidi Krenz; Mengjie Yao; Ahmed Daak

A Qualitative Study on Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia 关于免疫性血小板减少症患者体验其症状、体征及日常影响的定性研究

patient patient centered outcomes research

IF0

2025-08-16

OAAI

Waleed Ghanima; Nichola Cooper; Sylvie Bozzi; Ahmed Daak; Imene Gouia; Matias Cordoba; Javier Barrio; Michael Kostikas; Owen Cooper; Howard Liebman

Primary versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit

THROMBOSIS AND HAEMOSTASIS

IF4.3

2025-01-20

OAAI

Modi, Dimpy; Chowdhury, Saifur R.; Mahamad, Syed; Modi, Hayley; Cines, Douglas B.; Neunert, Cindy E.; Al-Samkari, Hanny; Cooper, Nichola; Moulis, Guillaume; Cunningham-Rundles, Charlotte; Liebman, Howard A.; Bussel, James B.; Breakey, Vicky R.; Nazy, Ishac; Arnold, Donald M.

Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

THERAPEUTIC ADVANCES IN HEMATOLOGY

IF3.1

2023-10-18

OAAI

Kuter, David J.; Bussel, James B.; Ghanima, Waleed; Cooper, Nichola; Gernsheimer, Terry; Lambert, Michele P.; Liebman, Howard A.; Tarantino, Michael D.; Lee, Michelle; Guo, Hailing; Daak, Ahmed

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2023-03-01

OAAI

Al-Samkari, Hanny; Jiang, Debbie; Gernsheimer, Terry; Liebman, Howard; Lee, Susie; Bernheisel, Chelsea; Wojdyla, Matthew; Vredenburg, Michael; Cuker, Adam

Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2021-08-01

OAAI

Cuker, Adam; Liebman, Howard A.

Understanding Immune Thrombocytopenia: Looking Out of the Box

FRONTIERS IN MEDICINE

IF3

2021-06-24

OAAI

Schifferli, Alexandra; Cavalli, Franco; Godeau, Bertrand; Liebman, Howard A.; Recher, Mike; Imbach, Paul; Kuhne, Thomas

Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method 在原发性免疫性血小板减少症中逐渐减少血小板生成素受体激动剂: 基于RAND/UCLA改良Delphi panel方法的专家共识

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS

IF3.4

2021-01-01

OAAI

Cuker, Adam; Despotovic, Jenny M.; Grace, Rachael F.; Kruse, Caroline; Lambert, Michele P.; Liebman, Howard A.; Lyons, Roger M.; McCrae, Keith R.; Pullarkat, Vinod; Wasser, Jeffrey S.; Beenhouwer, David; Gibbs, Sarah N.; Yermilov, Irina; Broder, Michael S.

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia 新型FcRn拮抗剂efgartigimod在成人原发性免疫性血小板减少症患者中的2期研究

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2019-12-10

117

OAAI

Newland, Adrian C.; Sanchez-Gonzalez, Blanca; Rejto, Laszlo; Egyed, Miklos; Romanyuk, Nataliya; Godar, Marie; Verschueren, Katrien; Gandini, Domenica; Ulrichts, Peter; Beauchamp, Jon; Dreier, Torsten; Ward, E. Sally; Michel, Marc; Liebman, Howard A.; de Haard, Hans; Leupin, Nicolas; Kuter, David J.

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2019-02-21

508

OAAI

Khorana, A. A.; Soff, G. A.; Kakkar, A. K.; Vadhan-Raj, S.; Riess, H.; Wun, T.; Streiff, M. B.; Garcia, D. A.; Liebman, H. A.; Belani, C. P.; O'Reilly, E. M.; Patel, J. N.; Yimer, H. A.; Wildgoose, P.; Burton, P.; Vijapurkar, U.; Kaul, S.; Eikelboom, J.; McBane, R.; Bauer, K. A.; Kuderer, N. M.; Lyman, G. H.

Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer

JCI INSIGHT

IF6.1

2019-02-21

122

OAAI

Zwicker, Jeffrey I.; Schlechter, Benjamin L.; Stopa, Jack D.; Liebman, Howard A.; Aggarwal, Anita; Puligandla, Maneka; Caughey, Thomas; Bauer, Kenneth A.; Kuemmerle, Nancy; Wong, Ellice; Wun, Ted; McLaughlin, Marilyn; Hidalgo, Manuel; Neuberg, Donna; Furie, Bruce; Flaumenhaft, Robert; Rickles, Frederick; Lenz, Heinz; Nieva, Jorge; Fuld, Alexander; Rodrigues, Anita; Bullock, Andrea; Bockorny, Bruno; Peters, Mary Linton; Zerillo, Jessica; Saverese, Diane

Cancer prognosis in patients with venous thromboembolism (VTE) and patients with clinical and laboratory biomarkers predictive of VTE risk

THROMBOSIS RESEARCH

IF3.4

2018-04-01

PREAI

Liebman, Howard A.

Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial

THROMBOSIS AND HAEMOSTASIS

IF4.3

2017-11-30

OAAI

Khorana, Alok A.; Vadhan-Raj, Saroj; Kuderer, Nicole M.; Wun, Ted; Liebman, Howard; Soff, Gerald; Belani, Chandra; O'Reilly, Eileen M.; McBane, Robert; Eikelboom, John; Damaraju, C. V.; Beyersl, Karen; Dietrichl, Flavia; Kakkar, Ajay K.; Riess, Hanno; Peixoto, Renata D'Alpino; Lyman, Gary H.

Autoimmune Hemolytic Anemia

MEDICAL CLINICS OF NORTH AMERICA

IF4.2

2017-03-01

PREAI

Liebman, Howard A.; Weitz, Ilene C.

Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia

HAEMATOLOGICA

IF7.9

2016-08-11

OAAI

Liebman, Howard A.; Saleh, Mansoor N.; Bussel, James B.; Negrea, O. George; Horne, Heather; Wegener, William A.; Goldenberg, David M.

Immune modulation for autoimmune disorders: evolution of therapeutics

SEMINARS IN HEMATOLOGY

IF4.1

2016-04-01

PREAI

Liebman, Howard A.

Incidental venous thromboembolic events in cancer patients: what we know in 2016

THROMBOSIS RESEARCH

IF3.4

2016-04-01

OAAI

Liebman, Howard A.; O'Connell, Casey

Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin

THROMBOSIS RESEARCH

IF3.4

2016-04-01

PREAI

Piatek, C. I.; Tagawa, S. T.; Wei-Tsai, D.; Hanna, D.; Weitz, I. C.; O'Connell, C.; Rochanda, L.; Groshen, S.; Liebman, H. A.

Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2016-01-01

102

OAAI

van der Hulle, T.; den Exter, P. L.; Planquette, B.; Meyer, G.; Soler, S.; Monreal, M.; Jimenez, D.; Portillo, A. K.; O'Connell, C.; Liebman, H. A.; Shteinberg, M.; Adir, Y.; Tiseo, M.; Bersanelli, M.; Abdel-Razeq, H. N.; Mansour, A. H.; Donnelly, O. G.; Radhakrishna, G.; Ramasamy, S.; Bozas, G.; Maraveyas, A.; Shinagare, A. B.; Hatabu, H.; Nishino, M.; Huisman, M. V.; Klok, F. A.

Management of immune-mediated cytopenias in pregnancy

AUTOIMMUNITY REVIEWS

IF8.3

2015-09-01

PREAI

Piatek, Caroline I.; El-Hemaidi, Ihab; Feinstein, Donald I.; Liebman, Howard A.; Akhtari, Mojtaba

研究方向